Two days ago, there is about 0.37% of stock shorted or about $470K. It isn't significant enough to worry about. Trust me, these will be the regular knobs who short all impending biotech announcements. I do agree that a lot of Market Sensitive biotech announcements are negative which is probably the strategy here. However, the chance for a failed trial is low. If and when this goes north we will get a nice volume boost from the knob shorters. We can't lose. That bounce off .73 today tells a story. Nice slow big breath - now relax.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.005(1.69%) |
Mkt cap ! $86.51M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 29.0¢ | $37.22K | 127.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8471 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 17050 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |